| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Oruka Therapeutics, Inc. (ORKA) has 4 insiders with recent SEC Form 4 filings, including 16 buys and 0 sells. ORKA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.13M | $81.89M | - | |
| COO | 218.1K | $15.78M | - | |
| Dir | 35.0K | $2.53M | - | |
| Other | 33.9K | $2.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 2, 2022 | Funicular Fund, LP53 | See Footnote 1 | Buy | 33,614 | $2.31 | $77,729.81 | +0.5% | +1.7% | -13.5% | |
| Apr 25, 2022 | Funicular Fund, LP53 | See Footnote 1 | Buy | 13,751 | $2.29 | $31,507.67 | +0.6% | -2.0% | -19.7% | |
| Apr 18, 2022 | Funicular Fund, LP53 | See Footnote 1 | Buy | 9,119 | $2.31 | $21,080.39 | +0.4% | +3.4% | -13.8% | |
| Apr 14, 2022 | Funicular Fund, LP53 | See Footnote 1 | Buy | 17,410 | $2.33 | $40,546.15 | +0.8% | +6.8% | -14.4% | |
| Apr 12, 2022 | Funicular Fund, LP53 | See Footnote 1 | Buy | 104,713 | $2.32 | $242,729.04 | +1.7% | +6.4% | -14.9% | |
| Apr 7, 2022 | Funicular Fund, LP53 | See Footnote 1 | Buy | 103,984 | $2.31 | $239,777.71 | +1.7% | +9.6% | -14.0% | |
| Apr 4, 2022 | Funicular Fund, LP53 | See Footnote 1 | Buy | 122,342 | $2.26 | $276,309.41 | +6.7% | +7.3% | -15.0% | |
| Nov 22, 2021 | Ozeroff Christopher David | S.v.p., General Counsel | Buy | 50,000 | $2.26 | $113,210.00 | +5,155% | -11.7% | -6.7% | |
| May 12, 2021 | Conway Robert E | Director, Chairman Of The Board | Buy | 10,000 | $3.19 | $31,947.00 | +25.0% | -4.1% | -28.1% | |
| May 5, 2021 | Conway Robert E | Director, Chairman Of The Board | Buy | 10,000 | $3.23 | $32,345.00 | +33.3% | -7.1% | -29.8% |